{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:30Z","timestamp":1791352290524,"version":"4.3.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jaad.2010.06.040","type":"journal-article","created":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T04:24:20Z","timestamp":1308716660000},"page":"517-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effective monitoring of isotretinoin safety in a pediatric dermatology population: A\u00a0novel \u201cpatient symptom survey\u201d approach"],"prefix":"10.1016","volume":"65","author":[{"given":"Chelsea J.","family":"Hodgkiss-Harlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalene A.","family":"Dohil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.06.040_bib1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1542\/peds.2005-2022","article-title":"Expert committee recommendations for acne management","volume":"118","author":"Zaenglein","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2010.06.040_bib2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0190-9622(80)80074-0","article-title":"The treatment of severe cystic acne with 13- cis-retinoic acid: evaluation of sebum production and the clinical response in a multiple-dose trial","volume":"3","author":"Farrell","year":"1980","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2010.06.040_bib3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0190-9622(98)70444-X","article-title":"The role of isotretinoin in the treatment of acne: personal observations","volume":"39","author":"Leyden","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib4","series-title":"Comprehensive dermatologic drug therapy","first-page":"269","article-title":"Systemic retinoids","author":"Nguyen","year":"2001"},{"key":"10.1016\/j.jaad.2010.06.040_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14740338.3.2.119","article-title":"Safety and side effects of the acne drug, oral isotretinoin","volume":"3","author":"Charakida","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaad.2010.06.040_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MOP.0b013e328305e273","article-title":"New insights into adolescent acne","volume":"20","author":"Tom","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaad.2010.06.040_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128072-200305050-00003","article-title":"Guidelines for the management of acne vulgaris in adolescents","volume":"5","author":"Goulden","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaad.2010.06.040_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","article-title":"Isotretinoin and the controversy of psychiatric adverse effects","volume":"45","author":"Strahan","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM199507133330206","article-title":"A pregnancy-prevention program in women of childbearing age receiving isotretinoin","volume":"333","author":"Mitchell","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.jaad.2010.06.040_bib10","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1067\/mjd.2001.113717","article-title":"Uses and complications of isotretinoin therapy","volume":"45","author":"Ellis","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00045391-200303000-00012","article-title":"Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide","volume":"10","author":"O'Donnell","year":"2003","journal-title":"Am J Ther"},{"key":"10.1016\/j.jaad.2010.06.040_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00128071-200304070-00005","article-title":"Isotretinoin use and subsequent depression and suicide: presenting the evidence","volume":"4","author":"Hull","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib13","first-page":"134","article-title":"Isotretinoin, depression and suicide: a review of the evidence","volume":"55","author":"Magin","year":"2005","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jaad.2010.06.040_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.sder.2005.04.003","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"24","author":"Marqueling","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.06.040_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.v69n0403","article-title":"Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study","volume":"69","author":"Azoulay","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2010.06.040_bib17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2466\/pr0.100.4.1312-1314","article-title":"Monitoring people treated with isotretinoin for depression","volume":"100","author":"Brasi\u0107","year":"2007","journal-title":"Psychol Rep"},{"key":"10.1016\/j.jaad.2010.06.040_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2466\/PR0.99.3.897-906","article-title":"Incidence of depression related to isotretinoin treatment in 100 acne vulgaris patients","volume":"99","author":"Kaymak","year":"2006","journal-title":"Psychol Rep"},{"key":"10.1016\/j.jaad.2010.06.040_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09546630410027472","article-title":"A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin","volume":"15","author":"Ferahbas","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2010.06.040_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1440-0960.2002.00612.x","article-title":"Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy","volume":"43","author":"Ng","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.det.2005.05.008","article-title":"Acne, depression, and suicide","volume":"23","author":"Hull","year":"2005","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2010.06.040_bib24","first-page":"613","article-title":"Current concepts in acne management","volume":"17","author":"Yan","year":"2006","journal-title":"Adolesc Med Clin"},{"issue":"Suppl","key":"10.1016\/j.jaad.2010.06.040_bib25","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1067\/mjd.2001.113719","article-title":"Analysis of common side effects of isotretinoin","volume":"45","author":"McLane","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.06.040_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/120347540000400205","article-title":"Isotretinoin use in acne: prospective evaluation of adverse events","volume":"4","author":"Hull","year":"2000","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.06.040_bib27","first-page":"484","article-title":"Adverse effects of isotretinoin therapy","volume":"33","author":"Bruno","year":"1984","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2010.06.040_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0190-9622(08)81018-3","article-title":"Acute depression from isotretinoin","volume":"22","author":"Scheinman","year":"1990","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210007553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210007553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:21:45Z","timestamp":1759270905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962210007553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0190962210007553"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.06.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective monitoring of isotretinoin safety in a pediatric dermatology population: A\u00a0novel \u201cpatient symptom survey\u201d approach","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}